Motivational interviewing for male couples to reduce drug use and HIV risk
Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples
This study is testing whether a special conversation technique for male couples can help reduce drug use and lower the risk of HIV.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 360 (estimated) |
| Ages | 18 Years to 55 Years |
| Sex | Male |
| Sponsor | Hunter College of City University of New York Academic / other |
| Locations | 3 sites (Detroit, Michigan and 2 other locations) |
| Trial ID | NCT06307977 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of couples motivational interviewing (MI) in reducing illicit drug use and HIV transmission risk behaviors among male couples. Participants are randomly assigned to either receive couples MI or standard couples HIV testing and counseling. The study aims to assess changes in drug use frequency and HIV risk behaviors over time. By focusing on couples, the intervention seeks to leverage relationship dynamics to promote healthier behaviors.
Who should consider this trial
Good fit: Ideal candidates are male couples where one partner is HIV negative and both have a history of drug use and HIV risk behaviors.
Not a fit: Patients who are not in a male couple relationship or those without recent drug use or HIV risk behaviors may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly lower drug use and HIV transmission rates among vulnerable male couples.
How similar studies have performed: Other studies have shown promise in using motivational interviewing for substance use and HIV risk reduction, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have a main partner who is another cisgender male and have been in a relationship for 3 month or longer * Index participant must be between 18 and 55; Main partner can be any age 18 and older * One participant must be HIV negative (as confirmed by rapid test) * One participant must have used at least 1 drug in the past 30 days (cocaine/crack, opiates, misuse of prescription medication, stimulants, psychedelics, ecstasy, ketamine, GHB, amyl nitrite) * Index participant must have engaged in TRB in the past 30 days- Defined as CAS with a casual partner, or a serodiscordant or non-monogamous main partner * Live in the United States * Speak and read English Exclusion Criteria * Any signs of serious mental illness or cognitive deficit * Current suicidal/homicidal ideations * History of IPV with their main partner and safety concerns in the current relationship.
Where this trial is running
Detroit, Michigan and 2 other locations
- Wayne State University — Detroit, Michigan, United States (Active_not_recruiting)
- Hunter College — New York, New York, United States (Recruiting)
- University of Virginia — Charlottesville, Virginia, United States (Active_not_recruiting)
Study contacts
- Study coordinator: Tyrel J Starks, PHD
- Email: tstarks@hunter.cuny.edu
- Phone: 212-206-7919
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.